Literature DB >> 16924127

Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis.

Rob J Longman1, Richard Poulsom, Anthony P Corfield, Bryan F Warren, Nicholas A Wright, Michael G Thomas.   

Abstract

Mucin glycoproteins and trefoil peptides play an important role in protection and repair of the gastrointestinal epithelium. This study investigates alterations in mucin and trefoil peptide gene expression and product localization in ulcerative colitis (UC). Product localization and message expression of mucin MUC1 to 6 and trefoil peptide TFF1 to 3 genes was analyzed in rectosigmoid tissue from a cohort of patients with active UC and compared with that of normal colorectal mucosa. MUC1 expression was upregulated in severe UC at the site of rupture of crypt abscesses. Reduction in MUC2 expression occurred in UC adjacent to ulceration. No alteration in MUC3 or MUC4 gene expression was detectable in UC compared with normal colorectal mucosa. No ectopic expression of MUC5AC, MUC5B, or MUC6 was identified in UC. Ectopic TFF1 expression was identified in tissues eliciting histological features of severe disease. Decreased TFF3 localization was demonstrated in UC tissues, but no TFF2 expression was detected in any colorectal specimens. Subtle alterations in composition of the supramucosal defense barrier exist in UC and vary in relation to clinical severity of disease. There is upregulation in mucin MUC1 at crypt abscesses and neo-expression of TFF1 trefoil peptide in severe disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924127      PMCID: PMC3958115          DOI: 10.1369/jhc.5A6904.2006

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  52 in total

1.  MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions.

Authors:  H W Hovenberg; J R Davies; A Herrmann; C J Lindén; I Carlstedt
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

Review 2.  Healing the epithelium: solving the problem from two sides.

Authors:  D K Podolsky
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

3.  Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium.

Authors:  R Poulsom; A M Hanby; E N Lalani; F Hauser; W Hoffmann; G W Stamp
Journal:  J Pathol       Date:  1997-09       Impact factor: 7.996

4.  Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma.

Authors:  K Nakagawa; J Akagi; E Takai; Y Tamori; T Okino; H Kako; H Egami; M Ogawa
Journal:  Int J Oncol       Date:  1999-03       Impact factor: 5.650

5.  Human gastric mucin. Identification of a unique species by expression cloning.

Authors:  N W Toribara; A M Roberton; S B Ho; W L Kuo; E Gum; J W Hicks; J R Gum; J C Byrd; B Siddiki; Y S Kim
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

6.  Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein.

Authors:  H Kindon; C Pothoulakis; L Thim; K Lynch-Devaney; D K Podolsky
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

7.  Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.

Authors:  H Mashimo; D C Wu; D K Podolsky; M C Fishman
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

8.  Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract.

Authors:  M C Rio; M P Chenard; C Wolf; L Marcellin; C Tomasetto; R Lathe; J P Bellocq; P Chambon
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

9.  Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats.

Authors:  M W Babyatsky; M deBeaumont; L Thim; D K Podolsky
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

10.  Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).

Authors:  P Y Fung; B M Longenecker
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

View more
  34 in total

Review 1.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.

Authors:  Laura M Ensign; Richard Cone; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2011-12-24       Impact factor: 15.470

2.  Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease.

Authors:  Haydn L Atkins; Mark S Geier; Luca D Prisciandaro; Ashok K Pattanaik; Rebecca E A Forder; Mark S Turner; Gordon S Howarth
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

3.  Milk fat globule-epidermal growth factor 8 is decreased in intestinal epithelium of ulcerative colitis patients and thereby causes increased apoptosis and impaired wound healing.

Authors:  Qiu-jie Zhao; Yan-bo Yu; Xiu-li Zuo; Yan-yan Dong; Yan-qing Li
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

4.  Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.

Authors:  Pamela L Beatty; Sowmya Narayanan; Jean Gariépy; Sarangarajan Ranganathan; Olivera J Finn
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

5.  Muc17 protects intestinal epithelial cells from enteroinvasive E. coli infection by promoting epithelial barrier integrity.

Authors:  Silvia Resta-Lenert; Srustidhar Das; Surinder K Batra; Samuel B Ho
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-10       Impact factor: 4.052

6.  Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.

Authors:  Maria Caruso; James Moore; Gregory J Goodall; Michelle Thomas; Stuart Phillis; Anna Tyskin; Glenice Cheetham; Nancy Lerda; Hiroyuki Takahashi; Andrew Ruszkiewicz
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

7.  Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.

Authors:  Deepak K Kadayakkara; Pamela L Beatty; Michael S Turner; Jelena M Janjic; Eric T Ahrens; Olivera J Finn
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

8.  Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer.

Authors:  S Das; S Rachagani; Y Sheinin; L M Smith; C B Gurumurthy; H K Roy; S K Batra
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

Review 9.  Trefoil factors in inflammatory bowel disease.

Authors:  Luise Aamann; Else Marie Vestergaard; Henning Grønbæk
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

10.  Mucin dynamics in intestinal bacterial infection.

Authors:  Sara K Lindén; Timothy H J Florin; Michael A McGuckin
Journal:  PLoS One       Date:  2008-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.